Difference in expression of two neurokinin-1 receptors in adenoma and carcinoma from patients that underwent radical surgery for colorectal carcinoma

Gao, Xia; Wang, Zhenjun

doi:10.3892/ol.2017.6588

Cited by 2 publications

(2 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Consistently, Pagan et al (61) showed that the administration of SR140333 (1 mg/kg), an NK1R antagonist, dose-dependently exerts proapoptotic functions via inducing the suppression of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and cyclooxygenase 2 (COX-2) signaling cascades in a rat model of CRC. To further support the regulatory role of TKs in CRC progression and development, Gao et al (62) indicated that interaction of truncated-NK1R (tr-NK1R), as a dominant form of NK1R, with its ligand probably play an essential role in the tumor microenvironment. In addition, these findings suggested that diminishing the expression of tr-NK1R may be used as a potential therapeutic strategy to prevent dysplasia of the colorectal adenomas from progressing to colorectal carcinomas (62).…”

Section: Tks and Colorectal Cancermentioning

confidence: 99%

“…To further support the regulatory role of TKs in CRC progression and development, Gao et al (62) indicated that interaction of truncated-NK1R (tr-NK1R), as a dominant form of NK1R, with its ligand probably play an essential role in the tumor microenvironment. In addition, these findings suggested that diminishing the expression of tr-NK1R may be used as a potential therapeutic strategy to prevent dysplasia of the colorectal adenomas from progressing to colorectal carcinomas (62). Besides, another in vitro study presented evidence that NKP608, as a selective and specific NK1R antagonist, leads to induced inhibiting the cell growth, invasion, migration, as well as enhanced programmed cell death in the human CRC cells, via suppressing the Wnt/β-catenin signaling axis (63).…”

Section: Tks and Colorectal Cancermentioning

confidence: 99%

See 1 more Smart Citation

The Role of Tachykinins in the Initiation and Progression of Gastrointestinal Cancers: A Review

Hashemian¹,

Javid

Tabrizi

et al. 2020

Int J Cancer Manag

View full text Add to dashboard Cite

Context: Tachykinins (TKs), an evolutionarily conserved family of peptide hormones, are widely distributed within the peripheral and central nervous systems. TKs exert their biological actions in many processes via three subtypes of transmembrane G-protein coupled receptors, which are NK1R, NK2R, and NK3R. Although the mechanisms that connect TKs peptide activity to physiological processes are currently precise, it has been shown that TKs over-activation is associated with the pathogenesis of many diseases, including pain, emesis, depression, stress, and inflammatory processes, as well as human tumors. Gastrointestinal (GI) cancers refer to malignant conditions of the GI tract, which are among the most prevalent diseases and are the leading cause of cancerrelated death worldwide. Recent studies have shown that the binding of TKs to specific cellular receptors mediates a critical GI tumor proliferation pathway via initiation and activation of effector mechanisms, including protein synthesis and progression of the eukaryotic cell cycle. Evidence Acquisition: This study reviewed the role of tachykinins in the initiation and progression of gastrointestinal cancers. In this regard we searched databases such as PubMed, Science Direct, Google Scholar, and Scopus databases by using these keywords "Tachykinins", "Gastrointestinal cancer", "Metastasis", "G-protein coupled receptors", and "pharmacological inhibitor" without any time limit. The relevance of studies was identified by reviewing the titles and the abstracts. A total of 100 English language articles including experimental, observational, molecular, and cellular studies were reviewed. Results: The administration of the gastrointestinal cancer cells with Tk receptor antagonists induces apoptotic cell death through the tachykinin-mediated pathway. The findings showed that the pharmacological inhibition of TKRs with its selective antagonists has a promising prospect for the GI cancers treatment approach, either as a single agent or in combination with other chemotherapeutic agents. Conclusions: In this review, we presented different facts regarding the role of TKs and TKRs in the pathogenesis of GI malignancies for a better understanding and hence better management of these cancers. Therefore, understanding the underlying mechanism of the TK/TKR system can help to have a more excellent clinical vision for the treatment of GI cancers.

show abstract

Section: Tks and Colorectal Cancermentioning

confidence: 99%